Author:
de la Presa Martin,McCafferty Brandon,Page Michael A.
Abstract
A case of Beauveria bassiana keratitis refractory to treatment with topical and systemic antifungal agents that demonstrated high-sensitivity profiles was presented. Clinical resolution was achieved within 1 month after the implementation of intrastromal injections of amphotericin B and micafungin. Keratitis from B. bassiana is a rare fungal species without a well-defined management strategy. To our knowledge, no previous reports have described the effectiveness or therapeutic use of intrastromal micafungin. This case report highlights a previously unreported treatment for cases of refractory keratitis from this rare fungal infection.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献